BGLC · Categories · Form 4
BGLC - SEC Form 4 insider transactions
BioNexus Gene Lab Corp (BGLC) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.
Recent Form 4 for BGLC
- Chief Executive Officer Tan Lee Su-Leng was granted 338,709 shares (SEC Form 4)4 - BioNexus Gene Lab Corp (0001737523) (Issuer)
- Director Yap Chee Keong was granted 32,258 shares (SEC Form 4)4 - BioNexus Gene Lab Corp (0001737523) (Issuer)
- Director Bin Abdul Hamid Muhammad Azrul was granted 32,258 shares (SEC Form 4)4 - BioNexus Gene Lab Corp (0001737523) (Issuer)
- Chief Financial Officer Chong Set Fui was granted 96,774 shares (SEC Form 4)4 - BioNexus Gene Lab Corp (0001737523) (Issuer)
- Director Low Jook Yuen was granted 16,129 shares, increasing direct ownership by 1,279% to 17,390 units (SEC Form 4)4 - BioNexus Gene Lab Corp (0001737523) (Issuer)